229 related articles for article (PubMed ID: 36012492)
21. miR-490-3p modulates the progression of prostate cancer through regulating histone deacetylase 2.
Fan H; Zhang YS
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):539-546. PubMed ID: 30720161
[TBL] [Abstract][Full Text] [Related]
22. Alterations of microRNAs and their predicted targeting mRNAs expression in RAW264.7 macrophages infected with Omp25 mutant Brucella melitensis.
Zhu H; Jiao H; Nie X; Li B; Xu K; Pang F; Cao R; Zhu S; Yang X; Zhang Z; Peng D; Li Y; Li G; Huang H; Chen C; Du L; Wang F
Innate Immun; 2018 Aug; 24(6):382-389. PubMed ID: 30092685
[TBL] [Abstract][Full Text] [Related]
23. Long non-coding TUG1 accelerates prostate cancer progression through regulating miR-128-3p/YES1 axis.
Hao SD; Ma JX; Liu Y; Liu PJ; Qin Y
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):619-632. PubMed ID: 32016963
[TBL] [Abstract][Full Text] [Related]
24. Transcriptional regulation of PRKAR2B by miR-200b-3p/200c-3p and XBP1 in human prostate cancer.
Xia L; Han Q; Chi C; Zhu Y; Pan J; Dong B; Huang Y; Xia W; Xue W; Sha J
Biomed Pharmacother; 2020 Apr; 124():109863. PubMed ID: 31986411
[TBL] [Abstract][Full Text] [Related]
25. miRNAs as cell fate determinants of lateral and paraxial mesoderm differentiation from embryonic stem cells.
Tuysuz EC; Ozbey U; Gulluoglu S; Kuskucu A; Sahin F; Bayrak OF
Dev Biol; 2021 Oct; 478():212-221. PubMed ID: 34245726
[TBL] [Abstract][Full Text] [Related]
26. miR-425-5p as an exosomal biomarker for metastatic prostate cancer.
Rode MP; Silva AH; Cisilotto J; Rosolen D; Creczynski-Pasa TB
Cell Signal; 2021 Nov; 87():110113. PubMed ID: 34371055
[TBL] [Abstract][Full Text] [Related]
27. Downregulation of miR-133a-3p promotes prostate cancer bone metastasis via activating PI3K/AKT signaling.
Tang Y; Pan J; Huang S; Peng X; Zou X; Luo Y; Ren D; Zhang X; Li R; He P; Wa Q
J Exp Clin Cancer Res; 2018 Jul; 37(1):160. PubMed ID: 30021600
[TBL] [Abstract][Full Text] [Related]
28. MiR-190a potentially ameliorates postoperative cognitive dysfunction by regulating Tiam1.
Liu Q; Hou A; Zhang Y; Guo Y; Li J; Yao Y; Niu K; Li H; Ma Y; Cao J
BMC Genomics; 2019 Aug; 20(1):670. PubMed ID: 31438846
[TBL] [Abstract][Full Text] [Related]
29. Novel prognostic markers in the serum of patients with castration-resistant prostate cancer derived from quantitative analysis of the pten conditional knockout mouse proteome.
Kälin M; Cima I; Schiess R; Fankhauser N; Powles T; Wild P; Templeton A; Cerny T; Aebersold R; Krek W; Gillessen S
Eur Urol; 2011 Dec; 60(6):1235-43. PubMed ID: 21741162
[TBL] [Abstract][Full Text] [Related]
30. Functional roles and potential clinical application of miRNA-345-5p in prostate cancer.
Tinay I; Tan M; Gui B; Werner L; Kibel AS; Jia L
Prostate; 2018 Sep; 78(12):927-937. PubMed ID: 29748958
[TBL] [Abstract][Full Text] [Related]
31. Microrna Expression Profiling of Macrophage Line Raw264.7 Infected by Candida Albicans.
Wu CX; Cheng J; Wang YY; Wang JJ; Guo H; Sun H
Shock; 2017 Apr; 47(4):520-530. PubMed ID: 27749761
[TBL] [Abstract][Full Text] [Related]
32. miR-199a-3p inhibits aurora kinase A and attenuates prostate cancer growth: new avenue for prostate cancer treatment.
Qu Y; Huang X; Li Z; Liu J; Wu J; Chen D; Zhao F; Mu D
Am J Pathol; 2014 May; 184(5):1541-9. PubMed ID: 24631181
[TBL] [Abstract][Full Text] [Related]
33. Biomarker Potential of Plasma MicroRNA-150-5p in Prostate Cancer.
Paunescu IA; Bardan R; Marcu A; Nitusca D; Dema A; Negru S; Balacescu O; Balacescu L; Cumpanas A; Sirbu IO; Petrut B; Seclaman E; Marian C
Medicina (Kaunas); 2019 Sep; 55(9):. PubMed ID: 31484346
[No Abstract] [Full Text] [Related]
34. Non-coding RNAs and related molecules associated with form-deprivation myopia in mice.
Liu S; Chen H; Ma W; Zhong Y; Liang Y; Gu L; Lu X; Li J
J Cell Mol Med; 2022 Jan; 26(1):186-194. PubMed ID: 34841657
[TBL] [Abstract][Full Text] [Related]
35. Genistein up-regulates tumor suppressor microRNA-574-3p in prostate cancer.
Chiyomaru T; Yamamura S; Fukuhara S; Hidaka H; Majid S; Saini S; Arora S; Deng G; Shahryari V; Chang I; Tanaka Y; Tabatabai ZL; Enokida H; Seki N; Nakagawa M; Dahiya R
PLoS One; 2013; 8(3):e58929. PubMed ID: 23554959
[TBL] [Abstract][Full Text] [Related]
36. Identifying the key genes and microRNAs in prostate cancer bone metastasis by bioinformatics analysis.
Zhu Z; Wen Y; Xuan C; Chen Q; Xiang Q; Wang J; Liu Y; Luo L; Zhao S; Deng Y; Zhao Z
FEBS Open Bio; 2020 Apr; 10(4):674-688. PubMed ID: 32027093
[TBL] [Abstract][Full Text] [Related]
37. Activin A regulates microRNAs and gene expression in LNCaP cells.
Ottley EC; Nicholson HD; Gold EJ
Prostate; 2016 Aug; 76(11):951-63. PubMed ID: 27018851
[TBL] [Abstract][Full Text] [Related]
38. Involvement of MiRNA-211-5p and Arhgap11a Interaction During Osteogenic Differentiation of MC3T3-E1 Cells.
Ju W; Zhang G; Zhang X; Wang J; Wu T; Li H
Front Surg; 2022; 9():857170. PubMed ID: 35495761
[TBL] [Abstract][Full Text] [Related]
39. Biomarker microRNAs for prostate cancer metastasis: screened with a network vulnerability analysis model.
Lin Y; Chen F; Shen L; Tang X; Du C; Sun Z; Ding H; Chen J; Shen B
J Transl Med; 2018 May; 16(1):134. PubMed ID: 29784056
[TBL] [Abstract][Full Text] [Related]
40. Hsa_circ_0007494 suppresses prostate cancer progression via miR-616/PTEN axis.
Zhang S; Zhang X; Chen G; Zheng X; Zhu X; Shan L
Exp Cell Res; 2020 Oct; 395(2):112233. PubMed ID: 32810511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
